A Study to Evaluate Nivolumab in the Treatment of Early Stage Esophageal or Gastroesophageal Cancer
Terminated · NCT05780736
Conditions: Esophageal Carcinoma, Gastroesophageal Junction Carcinoma
At a glance
- Research payments reported, 2025
- $52,912
- U.S. investigators named
- 10
- Sites paid
- 10
- Planned or actual enrollment
- 33
About the trial
- Sponsor
- Bristol-Myers Squibb (with PPD Development, LP)
- Dates
- Started 2023-08-04; completion 2024-08-23
- Results posted
- Not yet
The purpose of this study is to describe the effectiveness and use of nivolumab after surgery in participants with early stage (Stage II/III) Esophageal Cancer/Gastroesophageal Junction Cancer (EC/GEJC).
From ClinicalTrials.gov, last updated 2024-09-25. Full record, eligibility and contacts (opens in a new tab)
Industry funding
E.r. Squibb & Sons, L.l.c. reported $52,912 in research payments for this study in 2025 (10 payments).
Products named: Opdivo
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Shailendra Lakhanpal, M.D. Hematology & Oncology · Birmingham, AL
- Darryl A. Outlaw JR., M.D. Hematology & Oncology · Birmingham, AL
- Christina M. Gomez, M.D. Medical Oncology · Gilbert, AZ
- Thomas J. Spillane, MD Medical Oncology · San Luis Obispo, CA
- Bobby Chawla, D.O. Hematology & Oncology · Caldwell, ID
- Anwaar M. Saeed, M.D. Medical Oncology · Westwood, KS
- Robert C. Martin II, MD Surgical Oncology · Louisville, KY
- Manish A. Shah, MD Medical Oncology · New York, NY
- Nilesh Verma, M.D. Medical Oncology · Dallas, TX
- Lucas Wong, M.D. Hematology & Oncology · Temple, TX
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- University of Pittsburgh Cancer Institute Cancer Services $18,150
- Ut MD Anderson Cancer Center $6,169
- St Josephs Hospital and Medical Center, AZ $5,500
- Banner Casa Grande Medical Center, AZ $5,000
- Weill Medical College of Cornell University $4,616
- University of Alabama Hospital, AL $3,500
- Saint Alphonsus Regional Medical Center, ID $3,000
- Baylor Research Institute $2,750
- University of Louisville Research Foundation, Inc, $2,365
- Birmingham Hematology and Oncology Ass,llc $1,862
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.